Northern New England Clinical Oncology Society

Home
Leadership

Board

In Memorium

2020 Election

Nominations

Nomination Form

Board Fellow Liaisons

NAHPAC
Membership

Join

Renew

Corporate Membership
Education

2021 Virtual Spring Meeting

2021 Spring Meeting Abstracts

Lunchtime Best Oncology Practice Series

Regional Educational Programs
FUNDING

Research Funding

Student Project Funding

Funded Projects

Educational Program Grants

Presenter/Topic List

ASCO NNECOS Awards
PROJECTS

Clinical Trials Barrier Study

Oncology Care in Rural Northern New England
News

National Topics & Updates

News Blog

NH Oral Parity

Oral Parity Status Update

NNECOS Supports IDEA
Resources

About Us

Why NNECOS?

NNECOS History

Our Vision

Contact us

NNECOS Contact List

Drug Related Resources

Regional Reimbursement Contacts

Patient Access Programs

FDA Approvals

Code Updates

Packaging/Label Updates

Other Updates

COVID-19 Updates

Safety Updates

Member Resources

NNECOS Classifieds

Member Practices

Our member directory

Legislative Contact Information

Other Resources

Community Resources

Cancer Community Center

Healing Arts Program

On-Belay

Magnolia Meals at Home

Thank You Supporters

MACRA

Patient Navigation Resources

The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy.

Research Funding Deadline

Research Funding Deadline extended to 1/31/21

Strategic Plan Updates

ASCO Survey on COVID-19 in Oncology (ASCO) Registry

The American Society of Clinical Oncology (ASCO) Survey on COVID-19 in Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the patterns of symptoms and severity of COVID-19 among patients with cancer, as well as, how COVID-19 is impacting the delivery of cancer care and patient outcomes.

ASCO will deliver periodic reports with key findings so that the oncology community has real-time information to help inform treatment approaches for patients with cancer who have a confirmed COVID-19 infection. The reports will allow practices to easily and confidentially share information on COVID-19 infections among their patients.